Type 2 diabetes mellitus and clinical outcomes in patients with acute coronary syndrome during a one-year observation: own data and meta-analysis

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Article represents data on the impact of type 2 diabetes mellitus (T2DM) on the occurrence of adverse cardiovascular events within a year after acute coronary syndrome (ACS) based on the results of our own observational study ORACLE II (2014–2017). The obtained results are compared with the data of previously performed studies with similar aims and design.

The aim: to analyze clinical outcomes within a year after ACS occurrence in T2DM patients from Russian population and to compare the obtained results with the data of the world literature.

Material and methods. Meta-analysis of randomized multicenter prospective studies for 2008–2017 was performed. Data from 7 randomized clinical trials in patients who had undergone ACS and had a history of confirmed diagnosis of T2DM were used. Subsequently, the clinical outcomes of patients were analyzed during the year of observation after the index event.

Results. Patients with diabetes mellitus were significantly more likely to die from any cause within a year after ACS occurrence (risk difference (RD) 0.03; 95% confidence interval (CI): 0.01–0.04; p < 0.001), as well as directly from cardiovascular causes (RD 0.012; 95% CI: 0.007–0.017, p < 0.001) comparatively to patients without diabetes. Moreover, patients with type 2 diabetes mellitus had an increased risk of recurrent ACS (RR 0.013; 95% CI: 0.002–0.025, p = 0.019) and myocardial revascularization during the year of observation (RR 0.023; 95% CI: 0.017–0.029, p < 0.001), but not acute cerebrovascular accident (RR 0.0053; 95% CI: 0.0008–0.0099, p = 0.021). No significant differences were found in the incidence of bleeding in patients with and without T2DM (RR 0.004; 95% CI: 0.001–0.008, p = 0.145).

Conclusion. Presence of T2DM significantly increases the risk of overall mortality and cardiovascular events, including fatal ones, within a year after ACS, but the frequency of adverse outcomes is very variable.

Texto integral

Acesso é fechado

Sobre autores

Yuri Chichkov

United hospital with a polyclinic of the Facilities and Property Management Office under the RF President

Autor responsável pela correspondência
Email: umchichkov@mail.ru
ORCID ID: 0000-0002-0593-5193
Código SPIN: 1295-8403

MD, cardiologist

Rússia, Moscow

Larisa Minushkina

Central State Medical Academy of the Facilities and Property Management Office under the RF President

Email: minushkina@mail.ru
ORCID ID: 0000-0002-4203-3586
Código SPIN: 3654-8920

MD, Dr. Sci. (Medicine), professor of the Department of therapy, cardiology and functional diagnostics

Rússia, Moscow

Victoria Brazhnik

Central State Medical Academy of the Facilities and Property Management Office under the RF President; N.E. Bauman City Clinical Hospital No. 29 of the Department of Healthcare of Moscow

Email: vabrahznik@bk.ru
ORCID ID: 0000-0003-4144-4719
Código SPIN: 5627-9617

MD, Dr. Sci. (Medicine), associate professor of the Department of therapy, cardiology and functional diagnostics, chief physician

Rússia, Moscow; Moscow

Marina Chichkova

Clinical hospital No. 1 of the Facilities and Property Management Office under the RF President; Astrakhan State Medical University of the Ministry of Healthcare of Russia

Email: m.chichkova@mail.ru
ORCID ID: 0000-0002-6962-3260
Código SPIN: 5244-5358

MD, Dr. Sci. (Medicine), professor of the Department of cardiology, head of the Department of therapy No. 2

Rússia, Moscow; Astrakhan

Niyaz Khasanov

Kazan State Medical University of the Ministry of Healthcare of Russia

Email: ybzp@mail.ru
ORCID ID: 0000-0001-8582-708X
Código SPIN: 2501-3397

MD, Dr. Sci. (Medicine), associate professor, head of the Department of internal medicine propaedeutics

Rússia, Kazan

Olga Boeva

Central State Medical Academy of the Facilities and Property Management Office under the RF President

Email: box0271@mail.ru
ORCID ID: 0000-0002-1816-8309
Código SPIN: 4110-8448

MD, Dr. Sci. (Medicine), professor of the Department of therapy, cardiology and functional diagnostics

Rússia, Moscow

Elena Kosmacheva

Kuban State Medical University of the Ministry of Healthcare of Russia

Email: kosmachova_h@mail.ru
ORCID ID: 0000-0001-5690-2482
Código SPIN: 5277-2982

MD, Dr. Sci. (Medicine), professor, head of the Department of therapy No. 1 of the Faculty of advanced training and professional retraining of specialists

Rússia, Krasnodar

Dmitry Zateyshchikov

Central State Medical Academy of the Facilities and Property Management Office under the RF President; N.E. Bauman City Clinical Hospital No. 29 of the Department of Healthcare of Moscow

Email: dz@bk.ru
ORCID ID: 0000-0001-7065-2045
Código SPIN: 1694-3031

MD, Dr. Sci. (Medicine), professor, head of the Department of therapy, cardiology and functional diagnostics, head of the Primary Vascular Department

Rússia, Moscow; Moscow

Bibliografia

  1. Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Сазонова Д.В., Мокрышева Н.Г. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104–123. [Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Sazonova DV, Mokrysheva NG. Diabetes mellitus in the Russian Federation: Dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Sakharnyy diabet = Diabetes Mellitus. 2023;26(2):104–123 (In Russ.)]. EDN: DVDJWJ. https://doi.org/10.14341/dm13035
  2. Guan S, Xu X, Li Y, Li J, Guan M, Wang X et al. Impact of diabetes mellitus on antithrombotic management patterns and long-term clinical outcomes in patients with acute coronary syndrome: Insights from the EPICOR Asia Study. J Am Heart Assoc. 2020;9(22):e013476. PMID: 33164633. PMCID: PMC7763726. https://doi.org/10.1161/jaha.119.013476
  3. Karjalainen PP, Airaksinen JKE, de Belder A, Romppanen H, Kervinen K, Sia J et al. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: Insights from the BASE ACS trial. Ann Med. 2016;48(5):376–83. PMID: 27238465. https://doi.org/10.1080/07853890.2016.1186829
  4. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043–140. PMID: 37622663. https://doi.org/10.1093/eurheartj/ehad192
  5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. PMID: 33782057. PMCID: PMC8005924. https://doi.org/10.1136/bmj.n71
  6. Минушкина Л.О., Бражник В.А., Аверкова А.О. , Рогожина А.А., Евдокимова М.А., Королева О.С. с соавт. Острый коронарный синдром у больных с сахарным диабетом: объединенные данные многоцентровых наблюдательных исследований ОРАКУЛ I и ОРАКУЛ II. Терапия. 2019;5(1):68–80. [Minushkina LO, Brazhnik VA, Averkova AO, Rogozhina AA, Evdokimova MA, Korolyova OS et al. Acute coronary syndrome in patients with diabetes mellitus: Unified data of multicenter observational trials ORACLE I and ORACLE II. Terapiya = Therapy. 2019;5(1):68–80 (In Russ.)]. EDN: TYWAFN. https://dx.doi.org/10.18565/therapy.2019.1.68-80
  7. Winzap P, Davies A, Klingenberg R, Obeid S, Roffi M, Mach F et al. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: Role of the novel biomarker Cyr 61. Cardiovasc Diabetol. 2019;18(1):142. PMID: 31672144. PMCID: PMC6824030. https://doi.org/10.1186/s12933-019-0946-6
  8. Faggioni M, Baber U, Chandrasekhar J, Sartori S, Claessen BE, Rao SV et al. Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. Int J Cardiol. 2019;275:31–35. PMID: 30391067. https://doi.org/10.1016/j.ijcard.2018.10.071
  9. Hamilos M, Petousis S, Xanthopoulou I, Goudevenos J, Kanakakis J, Sitafidis G et al. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A GReek AntiPlatElet registry substudy. Coron Artery Dis. 2018;29(1):53–59. PMID: 28834792. https://doi.org/10.1097/mca.0000000000000547
  10. Wei C-C, Shyu K-G, Cheng J-J, Lo H-M, Chiu C-Z. Diabetes and adverse cardiovascular outcomes in patients with acute coronary syndrome – data from Taiwan’s acute coronary syndrome full spectrum data registry. Acta Cardiol Sin. 2016;32(1):31–38. PMID: 27171367. PMCID: PMC4804938. https://doi.org/10.6515/acs20150322a
  11. Li J, Li Y, Qiu M, Yang J, Wang X, Bao D et al. Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study. Catheter Cardiovasc Interv. 2020;95 Suppl 1:579–86. PMID: 31872515. https://doi.org/10.1002/ccd.28653
  12. Choi Y, Kang D-Y, Lee J, Lee J, Kim M, Kim H et al.; TICA KOREA Investigators. Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome and diabetes mellitus. JACC Asia. 2022;2(6):666–74. PMID: 36444315. PMCID: PMC9700022. https://doi.org/10.1016/j.jacasi.2022.07.005
  13. Hammoudeh AJ, Tabbalat R, Alhaddad IA, Khader Y, Jarrah M, Izraiq M, Al-Mousa E. Short- and long-term outcomes in Middle Eastern diabetic patients after percutaneous coronary intervention: Results from The First Jordanian PCI Registry (JoPCR1). Diabetol Int. 2016;8(1):30–38. PMID: 30603304. PMCID: PMC6224930. https://doi.org/10.1007/s13340-016-0273-z
  14. Lettino M, Andell P, Zeymer U, Widimsky P, Danchin N, Bardaji A et al.; PIRAEUS group. Diabetic patients with acute coronary syndromes in contemporary European registries: Characteristics and outcomes. Eur Heart J Cardiovasc Pharmacother. 2017;3(4):198–213. PMID: 28329196. https://doi.org/10.1093/ehjcvp/pvw049

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Fig. 1. PRISMA flow diagram for this study.

Baixar (173KB)
Metadados
3. Fig. 2. Meta-analysis of the proportion of patients with type 2 diabetes mellitus in the included studies: A - Funnel plot, B - Forest plot.

Baixar (81KB)
Metadados
4. Fig. 3. Differences in all-cause mortality risk during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p < 0.001, I2 = 87%)

Baixar (84KB)
Metadados
5. Fig. 4. Differences in cardiovascular mortality risk during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p < 0.001, I2 = 59%)

Baixar (81KB)
Metadados
6. Fig. 5. Differences in recurrent coronary event risk during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p = 0.019, I2 = 84%)

Baixar (80KB)
Metadados
7. Fig. 6. Differences in risk of repeat revascularizations during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p < 0.001, I2 = 55%)

Baixar (86KB)
Metadados
8. Fig. 7. Differences in stroke risk during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p = 0.021, I2 = 10%)

Baixar (85KB)
Metadados
9. Fig. 8. Differences in serious bleeding risk during one year of follow-up in patients with acute coronary syndrome with and without type 2 diabetes mellitus: A - Funnel plot, B - Forest plot (p = 0.145, I2 = 35%)

Baixar (83KB)
Metadados

Declaração de direitos autorais © Bionika Media, 2025